Project description
A health boost for genomic data
Healthcare is plagued by the challenge of inadequate treatments, with 3 out of 5 failing to deliver desired results. Enter Personalised Medicine, a discipline that is key to fixing these inefficiencies. However, it faces a major hurdle: astronomical volumes of numerical genomic data generated during DNA-based personalised diagnostics. In this context, the EU-funded ORIGAMI project will develop an algorithm to compress genomic data to enhance data transfer, storage, and analysis speed and precision. In a market projected to reach a staggering EUR 2 billion by 2025, it’s important to handle massive amounts of data. From improved compression rates and faster e-transfers to lighter storage and enhanced analysis, ORIGAMI will bring hope for a future where personalised medicine can thrive.
Objective
Healthcare is a worldwide challenge. To fight diseases, medicated treatments are common. However, statistics show that 3 out of 5
treatments are currently inadequate. Personalised Medicine is one of the fundamental discipline to fix those inefficient treatments.
Based on DNA, genomic sequencing is performed to achieve a personalised diagnostic for the patient. Unfortunately, this type of
medicine encounters some limitations. One of them is the astronomical amount of numerical genomic data that it generates. With
these volumes, transferring, storing, archiving and analysing the data become an issue. To counteract these issues, ENANCIO has
developed an algorithm, called Lena, to compress genomic data and improve the entire genomic data workflow. ENANCIO aims to
provide a solution to improve the transfer and storage of those data, but also to improve speed and precision of data analysis. There
is an urgent need to break down the barriers that exist by giving a genomic data compression solution which considers the entire
genomic data workflow. Currently, no compression solution adresses the entire dataflow. Such a technology is a new challenge.
Thanks to artificial intelligent value smoothing technology, ENANCIO aims to bring the only one technology improving the entire
value chain of the genomic data, from the improvement of the compression rate and compression time, allowing a faster e-transfer
and a lighter storage, to the improvement of the time and precision of analysis. Genomic data market has shown a fast raise and will
reach 2 billion € in 2025. ENANCIO addresses two categories of customers, private and academic sequencing platforms who manage
thousands giga bytes of data. During ORIGAMI project, ENANCIO aims to study the feasibility of the algorithm to fit with the latest
sequencers on the market, NovaSeq platform from Illumina (90% of market share). This new platform will be the standard of
tomorrow, justifying the need of compatibility with LENA algorithm.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences computer and information sciences data science
- natural sciences biological sciences genetics DNA
- medical and health sciences clinical medicine oncology breast cancer
- medical and health sciences health sciences personalized medicine
- natural sciences biological sciences genetics genomes
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
35510 CESSON-SEVIGNE
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.